-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.83240.96% Upside
Adaptimmune Therapeutics plc Frequently Asked Questions
-
What analysts cover Adaptimmune Therapeutics plc?
Adaptimmune Therapeutics plc has been rated by research analysts at H.C. Wainwright, Scotiabank, Mizuho Securities, Barclays, Wells Fargo in the past 90 days.